Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
1.420
-0.040 (-2.74%)
At close: Feb 21, 2025, 4:00 PM
1.490
+0.070 (4.93%)
After-hours: Feb 21, 2025, 4:27 PM EST
Fractyl Health Stock Forecast
GUTS's stock price has decreased by -82.53% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Fractyl Health stock has a target of 10, which predicts an increase of 604.23% from the current stock price of 1.42.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Fractyl Health stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Buy Maintains $18 → $10 | Buy | Maintains | $18 → $10 | +604.23% | Feb 3, 2025 |
Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 28, 2024 |
Morgan Stanley | Morgan Stanley | Buy Initiates $18 | Buy | Initiates | $18 | +1,167.61% | Feb 27, 2024 |
Financial Forecast
Revenue This Year
51.00K
from 120.00K
Decreased by -57.50%
Revenue Next Year
n/a
from 51.00K
EPS This Year
-1.46
from -45.29
EPS Next Year
-1.85
from -1.46
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 105,000 | n/a | n/a |
Avg | 51,000 | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | -12.5% | - | - |
Avg | -57.5% | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.50 | -1.90 | -1.85 |
Avg | -1.46 | -1.85 | -1.80 |
Low | -1.40 | -1.77 | -1.72 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.